Literature DB >> 16583789

The effect of depression on health care utilization and costs in patients with type 2 diabetes.

Iftekhar D Kalsekar1, Suresh M Madhavan, Mayur M Amonkar, Virginia Scott, Stratford M Douglas, Eugene Makela.   

Abstract

The objective of the study was to estimate the effect of depression on health care utilization and costs in patients newly diagnosed with type 2 diabetes. Patients were identified during a four-year enrollment period (1998-2001) from a Medicaid claims database. The final cohort consisted of 4,294 patients with type 2 diabetes (1,525 patients with depression; 2,769 patients without depression). Multivariate results indicated that significant utilization differences existed between the two groups: Patients who were depressed incurred a higher number of physician office visits, emergency room/inpatient admissions, and more prescriptions compared with patients who had diabetes but were not depressed. Patients with depression had nearly 65% higher overall health care costs than those without depression. Recognizing that depression is as a risk factor for increasing health care expenditures has the potential to improve diabetes management and related outcomes.

Entities:  

Mesh:

Year:  2006        PMID: 16583789

Source DB:  PubMed          Journal:  Manag Care Interface        ISSN: 1096-5645


  11 in total

1.  Impact of diagnosed depression on healthcare costs in adults with and without diabetes: United States, 2004-2011.

Authors:  Leonard E Egede; Kinfe G Bishu; Rebekah J Walker; Clara E Dismuke
Journal:  J Affect Disord       Date:  2016-02-09       Impact factor: 4.839

2.  Impact of social role strain, depression, social support and age on diabetes self-efficacy in Korean women with type 2 diabetes.

Authors:  Hyunjeong Park; Miyong T Kim
Journal:  J Cardiovasc Nurs       Date:  2012 Jan-Feb       Impact factor: 2.083

Review 3.  Healthcare costs in patients with diabetes mellitus and comorbid mental disorders--a systematic review.

Authors:  N Hutter; A Schnurr; H Baumeister
Journal:  Diabetologia       Date:  2010-08-11       Impact factor: 10.122

Review 4.  Aging, diabetes, and the public health system in the United States.

Authors:  Carl J Caspersen; G Darlene Thomas; Letia A Boseman; Gloria L A Beckles; Ann L Albright
Journal:  Am J Public Health       Date:  2012-06-14       Impact factor: 9.308

5.  Distress and Living with Diabetes: Defining Characteristics Through an Online Survey.

Authors:  Unaiza Waheed; Adrian H Heald; Mike Stedman; Emma Solomon; Rustam Rea; Saydah Eltom; J Martin Gibson; Katherine Grady; Arie Nouwen; Gerry Rayman; Angela Paisley
Journal:  Diabetes Ther       Date:  2022-07-13       Impact factor: 3.595

6.  Gender differences in morbidity and health care utilization among adult obstructive sleep apnea patients.

Authors:  Sari Greenberg-Dotan; Haim Reuveni; Tzahit Simon-Tuval; Arie Oksenberg; Ariel Tarasiuk
Journal:  Sleep       Date:  2007-09       Impact factor: 5.849

7.  Resource use among patients with diabetes, diabetic neuropathy, or diabetes with depression.

Authors:  Trong K Le; Stephen L Able; Maureen J Lage
Journal:  Cost Eff Resour Alloc       Date:  2006-10-23

8.  Prevalence of depressive symptoms among older adults who reported medical cost as a barrier to seeking health care: findings from a nationally representative sample.

Authors:  Vinay K Cheruvu; Edward T Chiyaka
Journal:  BMC Geriatr       Date:  2019-07-18       Impact factor: 3.921

9.  Healthcare technician delivered screening of adults with diabetes to improve primary care provider recognition of depression.

Authors:  Melissa Scollan-Koliopoulos; Iris Herrera; Karen Romano; Carrie Gregory; Kenneth Rapp; David Bleich
Journal:  J Family Med Prim Care       Date:  2012-07

10.  Impact of mental health visits on healthcare cost in patients with diabetes and comorbid mental health disorders.

Authors:  Leonard E Egede; Mulugeta Gebregziabher; Yumin Zhao; Clara E Dismuke; Rebekah J Walker; Kelly J Hunt; R Neal Axon
Journal:  PLoS One       Date:  2014-08-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.